Tyra Biosciences

Forecast & Rating15 analysts currently cover Tyra Biosciences, with about 93.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $47.45, about 153.8% upside from the current price of $18.70. Price targets range from $29.00 to $59.00 — a wide spread, showing clear disagreement over just how much Tyra Biosciences can rise. Historically, about 75.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Tyra Biosciences closely still see room for the stock to rise. Data as of Oct 6, 2026; for reference only and not investment advice.